Based on ongoing recommendations for social distancing, due to the coronavirus pandemic, Octane’s 2020 Ophthalmology Technology Summit in August will be 100% virtual. This decision was made, in part, by industry partners and physicians, as well as planning committee and
NEWS: SoCal Startup Funding Roundup May 25-29: Workspace, Jcyte, Fernish, Stackin’, Datch, Qualigen Therapeutics, Ascus Biosciences, Platform Science, Apeel Sciences…
Here are startups throughout SoCal that announced receiving investments this week. Newport Beach (commercial real estate software): Workspace received an undisclosed investment. The funding comes from ASG and its affiliates, a collection of vertically focused Software-as-a-Service companies. Workspace built a cloud-based
NEWS: Octane Creates Advisory Roles for Ophthalmology and Aesthetics. Two New Advisories to Convene Physicians to Discuss Groundbreaking Medical Technologies
Octane, a multi-faceted organization including the LaunchPad accelerator, created two new advisory opportunities: Octane Medical Advisor, Ophthalmology and Octane Medical Advisor, Aesthetics to convene physicians that are a part of the Octane ecosystem and to engage more KOL/physicians in future
NEWS: OC Could See $100 Million Fund Close by Mid-Year. Visionary Ventures Fund II Would be the First $100M Fund in OC….
The Visionary Ventures Fund II LP has set its sights on being the first $100 million venture fund in OC. Octane -- the multi-faceted organization and event presenter with a tech and life sciences accelerator in Aliso Viejo -- created the
It’s official. OCTANe has launched the sequel fund to its first Visionary Ventures LP fund. This one, known as Visionary Ventures II LP, will be a more diversified fund with a primary focus on ophthalmology. Its secondary focus will be on
With a successful ophthalmology fund under its belt and a sequel fund on the way, OCTANe is now looking to replicate the success that this specialized focus has achieved, this time in the fintech and data analytic realms. Bill Carpou, CEO
*NEWS: Novartis Confirmation of Alcon Spinoff Happens to Coincide with OCTANe’s Ophthalmology Technology Summit. Alcon Says Will Keep Manufacturing and BD&L in OC.
OCTANe’s annual 2018 Ophthalmology Technology Summit on June 29 coincided with the national news that Novartis will definitely spin off Alcon – with a presence in Lake Forest - to shareholders and buy back up to $5 billion in stock,
An OC-based fund dedicated to ophthalmology ventures has been a success for investors and a sequel fund will be launched. That’s the news relayed Friday by Visionary Ventures Fund LP Managing Partner Jeffry Weinhuff. He announced the news at OCTANe’s annual
Entrepreneur innovators have catalyzed the ophthalmology industry from the get-go, starting with one of the first - Gavin Herbert, who created Allergan more than 50 years ago. Allergan evolved into a multinational pharma company that produces branded drugs and does